Skip to main content
Clinical Trials/CTRI/2020/12/029585
CTRI/2020/12/029585
Not Yet Recruiting
N/A

Effect of non-invasive ventilation with high-flow nasal oxygen therapy in COVID 19 patients. - NIVHOC

All India Institute Of Medical Sciences Patna0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute Of Medical Sciences Patna
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
All India Institute Of Medical Sciences Patna

Eligibility Criteria

Inclusion Criteria

  • 1 Adult (Age \>18years)
  • 2 Confirmed COVID 19 patients tested positive for SARS\-CoV\-2 via nasopharyngeal swab by RT\-PCR test and admitted to intensive care unit.
  • 3 Acute hypoxemic respiratory failure defined by respiratory rate \>\=25 breaths/min, and PaO2/FiO2 \<\=300 mm Hg while spontaneously breathing under standard oxygen therapy.

Exclusion Criteria

  • Patients will be excluded if PaCO2 above 50 mm Hg, underlying chronic lung disease, cardiogenic pulmonary edema, severe shock, impending cardiopulmonary arrest, Glasgow coma scale score lower than 8 \& absence of airway protective gag reflex.

Outcomes

Primary Outcomes

Not specified

Similar Trials